| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |